Description
COVID-19 EMERGENCY VEKLURY REMDESIVIR - CI
First action · last action
2020-11-09 · 2023-02-06
Transactions
2
First transaction's obligation
$291,938
Base + all options value (sum of deltas)
$81,743
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70252
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-11-09+$291,938= $291,938
- Mod P000012023-02-06-$210,195= $81,743
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-11-09 | +$291,938 | $291,938 | COVID-19 EMERGENCY VEKLURY REMDESIVIR - CI |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-02-06 | −$210,195 | $81,743 | COVID-19 EMERGENCY VEKLURY REMDESIVIR - CI |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI FPJMGUK1BYH8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26125N0499 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $14,894 | FY2025 |
| 36C26025F0137 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $3,103 | FY2025 |
| 36C26025F0134 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $2,482 | FY2025 |
| 36C24524N0911 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $14,938 | FY2024 |
| 36C26024F0466 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $47,797 | FY2024 |
| 36C26024F0440 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $47,797 | FY2024 |
Other recipients under 6505 from NETWORK CONTRACT OFFICE 23 (36C263) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26326F0080 | MEDI-PHYSICS, INC. | NETWORK CONTRACT OFFICE 23 (36C263) | $27,788 | FY2026 |
| 36C26326N0517 | HOT SHOTS NM LLC | NETWORK CONTRACT OFFICE 23 (36C263) | $87,320 | FY2026 |
| 36C26326D0053 | HOT SHOTS NM LLC | NETWORK CONTRACT OFFICE 23 (36C263) | $0 | FY2026 |
| 36C26326P0460 | PROFOUNDA INC | NETWORK CONTRACT OFFICE 23 (36C263) | $49,950 | FY2026 |
| 36C26326N0416 | CARDINAL HEALTH 414, LLC | NETWORK CONTRACT OFFICE 23 (36C263) | $761,773 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26321N0248_3600_V797D70252_3600 · retrieved 2026-09-27.